Literature DB >> 3010759

Primary adenoid cystic carcinoma of the skin. A clinical, histological, and immunocytochemical comparison with adenoid cystic carcinoma of salivary glands and adenoid basal cell carcinoma.

M R Wick, P E Swanson.   

Abstract

An adenoid cystic carcinoma of the skin was compared with three similar neoplasms of salivary glands and with an adenoid basal cell carcinoma, from unrelated cases. The histological and immunocytochemical details of these tumors were analyzed in an attempt to determine whether or not their differing clinical behaviors would be reflected in pathologic dissimilarities. Although the single adenoid cystic carcinoma of the skin did not recur or metastasize over a 10-year follow-up period, its morphologic and biochemical features were identical to those of biologically aggressive salivary gland tumors. All four adenoid cystic carcinomas contained carcinoembryonic antigen, epithelial membrane antigen, salivary-type amylase, and alpha-lactalbumin, and all bound peanut agglutinin. Three of four expressed positivity for S100 protein, and two contained low-molecular-weight cytokeratin. In contrast, none was immunoreactive for beta-2-microglobulin, and only one displayed blood group isoantigen positivity. The adenoid basal cell carcinoma was negative for all immunological determinants, but it bound peanut agglutinin. Although these results should be regarded as preliminary, it appears that adenoid cystic carcinoma is a pathologically distinct and uniform entity, whether it occurs in the skin or in salivary glands. However, the clinical behavior of this tumor cannot be predicted on the basis of immunohistochemical or morphological studies. Finally, adenoid basal cell carcinoma is histopathologically and immunocytochemically separable from cutaneous adenoid cystic carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3010759     DOI: 10.1097/00000372-198602000-00002

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  8 in total

1.  Primary cutaneous adenoid cystic carcinoma in the United States: incidence, survival, and associated cancers, 1976 to 2005.

Authors:  Graça M Dores; Mark M Huycke; Susan S Devesa; Carlos A Garcia
Journal:  J Am Acad Dermatol       Date:  2010-05-05       Impact factor: 11.527

Review 2.  [Sweat gland carcinomas of the skin].

Authors:  A Rütten; L Requena
Journal:  Hautarzt       Date:  2008-02       Impact factor: 0.751

3.  Adenoid cystic carcinoma arising from the lower eyelid.

Authors:  Hiroshi Goto; Tatsuro Yamamoto; Zenzo Ishiyama; Masahiko Usui; Shinya Okada
Journal:  Jpn J Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 2.447

4.  Primary cutaneous adenoid cystic carcinoma with MYB aberrations: report of three cases and comprehensive review of the literature.

Authors:  Carlos N Prieto-Granada; Lei Zhang; Cristina R Antonescu; Jean M Henneberry; Jane L Messina
Journal:  J Cutan Pathol       Date:  2016-12-02       Impact factor: 1.587

5.  Cutaneous adenoid cystic carcinoma with perineural invasion treated by mohs micrographic surgery-a case report with literature review.

Authors:  Yaohui G Xu; Molly Hinshaw; B Jack Longley; Humza Ilyas; Stephen N Snow
Journal:  J Oncol       Date:  2010-04-07       Impact factor: 4.375

Review 6.  [Skin adnexal and salivary gland neoplasms. Similarities and differences of selected patients].

Authors:  T Mentzel
Journal:  Pathologe       Date:  2004-02       Impact factor: 1.011

7.  Two Different Cell Populations Is an Important Clue for Diagnosis of Primary Cutaneous Adenoid Cystic Carcinoma: Immunohistochemical Study.

Authors:  Banu Ince Alkan; Onder Bozdogan; Müjde Karadeniz; Nazan Bozdoğan
Journal:  Case Rep Pathol       Date:  2017-01-24

8.  Metastasis of Primary Cutaneous Adenoid Cystic Carcinoma to the Nasal Septum after 17 years: A Case Report.

Authors:  Yohei Takada; Tomoko Takada; Sachie Takayasu; Yuhei Ogino; Yuka Higashiyama; Kenta Fukui; Daiki Sakamoto; Mikiya Asako; Hiroshi Iwai
Journal:  Case Rep Oncol       Date:  2022-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.